Cargando…

AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis

BACKGROUND: The present study aimed to systematically evaluate the diagnostic value of an isoform of alpha-fetoprotein (AFP), AFP-L3, for early hepatocellular carcinoma (HCC) by a meta-analysis. METHODS: Diagnostic reports of AFP-L3% in early HCC were searched in the PubMed, Web of Science, Cochrane...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jian-Ming, Wang, Ting, Zhang, Kun-He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556013/ https://www.ncbi.nlm.nih.gov/pubmed/34713864 http://dx.doi.org/10.1097/MD.0000000000027673

Ejemplares similares

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
por: Park, Sang Joon, et al.
Publicado: (2017)

Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis
por: Wang, Xueying, et al.
Publicado: (2020)

Combination therapy: Meta-analysis of the effects of TACE and cryoablation on hepatocellular carcinoma
por: Yuan-Dong, Sun, et al.
Publicado: (2019)

Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinoma: A meta-analysis
por: Fang, Ping, et al.
Publicado: (2020)

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
por: Wang, Ting, et al.
Publicado: (2020)

Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Li, Mu-xing, et al.
Publicado: (2015)

The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma
por: Zhao, Rongce, et al.
Publicado: (2017)

The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Pang, Qing, et al.
Publicado: (2015)

Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis
por: Lan, Tian, et al.
Publicado: (2016)

Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: A PRISMA-compliant systematic review and meta-analysis
por: Han, Jie, et al.
Publicado: (2020)

The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis
por: Rong, Xiaoxiang, et al.
Publicado: (2015)

The effectiveness of tivantinib for MET-high hepatocellular carcinoma: A protocol for meta analysis
por: Wang, Yubin, et al.
Publicado: (2023)

Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
por: Ren, Tianying, et al.
Publicado: (2023)

Effects of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma: A meta-analysis
por: Long, Guan-Bao, et al.
Publicado: (2020)

The association between pretreatment serum alkaline phosphatase and prognosis in hepatocellular carcinoma: A meta-analysis
por: Sun, Ping, et al.
Publicado: (2020)

Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis
por: An, Pei-Pei, et al.
Publicado: (2020)

HAIC versus TACE for patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Liu, Junguo, et al.
Publicado: (2022)

Inflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resection
por: Zhu, Ying, et al.
Publicado: (2017)

Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk: An update meta-analysis and trial sequential analysis
por: Wang, Binfeng, et al.
Publicado: (2021)

Accuracy of using serum D-dimer for diagnosis of acute intestinal ischemia: A meta-analysis
por: Sun, Da-Li, et al.
Publicado: (2017)

A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma
por: De, Ji, et al.
Publicado: (2016)

Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guideline
por: Zhu, Chunxiao, et al.
Publicado: (2017)

Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis
por: Chang, Yue, et al.
Publicado: (2020)

Long non-coding RNA SNHG16 as a potential biomarker in hepatocellular carcinoma: A meta-analysis
por: Liu, Qiuli, et al.
Publicado: (2021)

Risk factors of infection after transarterial chemoembolization for hepatocellular carcinoma: A protocol for systematic review and meta-analysis
por: Shi, Zhipeng, et al.
Publicado: (2021)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy
por: Yan, Xiaopeng, et al.
Publicado: (2016)

Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis
por: Xiao, Qi, et al.
Publicado: (2016)

Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma: A meta-analysis
por: Wang, Bolin, et al.
Publicado: (2020)

Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Clinicopathological Analysis of Factors Predictive of Recurrence and Outcome After Surgery
por: Zeng, Hong, et al.
Publicado: (2015)

Survival prediction model for postoperative hepatocellular carcinoma patients
por: Ren, Zhihui, et al.
Publicado: (2017)

Trans-catheter arterial chemoembolization plus Sorafenib, an unsuccessful therapy in the treatment of hepatocellular carcinoma?: A systematic review and meta-analysis
por: Zhang, Tao, et al.
Publicado: (2020)

Survival comparison between radiofrequency ablation and surgical resection for patients with small hepatocellular carcinoma: A systematic review and meta-analysis
por: Xuan, Dongchun, et al.
Publicado: (2021)

Global trends of targeted therapy for hepatocellular carcinoma: A bibliometric and visualized study from 2008 to 2022
por: Yang, Xuan-Ang, et al.
Publicado: (2023)

Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of hepatocellular carcinoma (HCC)
por: Li, Mengting, et al.
Publicado: (2021)

The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma
por: Qi, Famei, et al.
Publicado: (2019)

Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis
por: Coppola, Nicola, et al.
Publicado: (2016)

Clinical efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib in the treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
por: Du, Sihao, et al.
Publicado: (2023)

Survival benefit of radiofrequency ablation for solitary (3–5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry
por: Lee, Seung Ho, et al.
Publicado: (2017)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_69hdlv0fm3me4qnbljq2iduedi